Thursday, September 15, 2016, 9:30 am to 1:30 pm
Palazzo Rospigliosi, Via Ventiquattro Maggio, 43 – Rome.
Over the last fifty years, life expectancy has increased significantly (more than eleven years in countries with advanced economies) and, in large part, this is due to the contribution of innovative medicine.
The research and development process of a drug is long and consists of a series of phases, of which clinical study is a very important part.
Clinical testing generates benefits for patients in more rapid access to innovation, to the national health care system in sustainability and innovation, and, more generally, for the contribution it makes to the competitiveness and attractiveness of the entire nation and its economy. For this to occur, all the various stakeholders involved must collaborate efficiently from the initial phases of the clinical testing process.
This Forum, organized by The European House – Ambrosetti to mark the 10th anniversary of Celgene in Italy, offers an opportunity to share and discuss the value of clinical research for scientific progress, the health of the citizenry and the economic growth of the nation and its economy.
The issues that will be covered at the Forum include:
During the Forum, the “Celgene Research Awards” competition will be presented.
Partner, The European House - Ambrosetti